Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: A randomized multicentre survey in 12 city hospitals of China

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 6, 2010, Pages 481-489

  Liu, Fang ^a   Bao, Yuqian ^a   Hu, Renming ^b   Zhang, Xiuzhen ^c   Li, Hong ^d   Zhu, Dalong ^e   Li, Yanbing ^f   Yan, Li ^f   Li, Yuxiu ^g   Lu, Juming ^h   Li, Qiang ⁱ   Zhao, Zhigang ^j   Ji, Qiuhe ^k   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g General Hospital of the People's Liberation Army   (China)

^h Peiking Union Medical University   (China)

ⁱ HARBIN MEDICAL UNIVERSITY   (China)

^j Henan People's Hospital   (China)

^k FOURTH MILITARY MEDICAL UNIVERSITY   (China)

more..

Author keywords

10 g Semmes Weinstein monofilament; 128 Hz tuning fork; Outpatients; Peripheral neuropathy; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CHINA; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTION DISORDER; PERIPHERAL NEUROPATHY; PRESSURE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCREENING TEST; VIBRATION;

ADULT; AGE FACTORS; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; RISK FACTORS; SENSATION; VIBRATION;

EID: 77956636553     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1107     Document Type: Article

References (27)

1. Boulton AJ. The diabetic foot: a global view. Diabetes Metab Res Rev 2000; 16(1): S2-S5.
2. Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009; 35(3): 206-211.
3. Gale EA. Glucose control in the UKPDS: what did we learn? Diabet Med 2008; 25(Suppl 2): 9-12.
4. Pop-Busui R, Low PA, Waberski BH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Diabetes Care 2007; 30(10): 2613-2618.
5. American Diabetes Association. Standards of medical care in diabetes - 2008 edition. Diabetes Care 2008; 31(Suppl 1): S12-S54.
6. Tres GS, Lisbôa HR, Syllos R, Canani LH, Gross JL. Prevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil. Arq Bras Endocrinol Metab 2007; 51(6): 987-982.
7. Adler AI, Boyko EJ, Ahroni JH, et al. Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997; 20(7): 1162-1167.
8. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian first nation community. Diabetes Care 2008; 31(9): 1837-1841.
9. Jia WP, Shen Q, Bao YQ, Lu JX, Li M, Xiang KS. Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy. Chin Med J (Chinese) 2006; 6(38): 2707-2710.
10. Song QF, Song GY. Analysis of risk factors of diabetic peripheral neuropathy in type 2 diabetes patients. Chin J Gerontol (Chinese) 2009; 29(2): 222-224.
11. Hou RF, Tang ZY, Zhang W, et al. The comparison of diagnostic efficiency on diabetic peripheral neuropathy by multiple screening methods. Chin J Diabetes (Chinese) 2008; 16(2): 91-94.
12. Chinese Diabetes Association. Hypoglycemic treatment of type 2 diabetes. In Chinese Guideline for the Diagnosis and Treatment of Type 2 Diabetes (2007 Edition). Beijing University: Beijing, 2008; 30 (Suppl 1): S10-S11.
13. Apelqvist J, Bakker K, Van Houtum WH, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) prepared by the International Working Group on the Diabetic Foot. International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Diabetes Metab Res Rev 2008; 24(Suppl 1): S181-S187.
14. Perkins BA, Zinman B, Olyleye D, Bril V. Simple screening tests for peripheral neuropathy in the diabetic clinic. Diabetes Care 2001; 24(2): 250-256.
15. Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998; 21(10): 1749-1752.
16. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia 1996; 39(11): 1377-1384.
17. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Prac 2001; 54(2): 115-128.
18. Van de Poll-Franse LV, Valk GD, Renders CM, Heine RJ, Van Eijk JT. Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med 2002; 19(9): 771-776.
19. Kamei N, Yamane K, Nakanishi S, et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabet Compli 2005; 19(1): 47-53.
20. Pop-Busui R, Lu J, Lopes N, Jones TL; BARI 2D Investigators. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 2009; 14(1): 1-13.
21. Gregg EW, Sorlie P, Paulose-Ram R, et al.; 1999-2000 National health and nutrition examination survey. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes. Diabetes Care 2004; 27(9): 1591-1597.
22. Grimaldi A, Grange V, Allannic H, Passa P, Rodier M, Cornet P. Epidemiological analysis of patient with type 2 diabetes in France. J Diabetes Complicat 2000; 14(5): 247-249.
23. Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy. Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study Cohort. Diabetes Care 1999; 22(9): 1479-1486.
24. Kärvestedt L, Mårtensson E, Grill V, et al. Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care 2009; 32(2): 317-322.
25. Tesfaye S, Chaturvedi N, Eaton SE, et al.; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352(4): 341-350.
26. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44(11): 1973-1988.
27. Elliott J, Tesfaye S, Chaturvedi N, et al.; EURODIAB Prospective Complications Study Group. Large fibre dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care 2009; 32(10): 1896-1900.